Pathfinders in Biopharma
by RBC Capital Markets
September 30, 2024 11:00 pm
Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.
Recent Episodes
Former Investor Who Chose Broadcasting Over Biotech ETFs
2 months agoCan AI Solve Molecule Mysteries that will Unlock Simpler Drug Discovery?
3 months agoShots-on-Goal Licensing Company Aims for Breakthroughs
4 months agoWhy Biopharma Needs to Tell Better Stories on Novel Drugs
4 months agoVenture capital velocity: What’s driving renewed momentum in biotech?
4 months agoPharma Understands Phase One Data – But Does the Market?
5 months agoDavern Capital sees GLP-1 Opportunities Beyond Obesity
5 months agoBetting on Healthcare’s Future Hits – and Misses
5 months agoInnovation and an Aging Population Drive MedTech
5 months agoBiopharma Investors See Opportunities in Targeted Treatments and Gene Editing
6 months ago